Literature DB >> 11874149

Percutaneous endoscopic gastrostomy--indications and outcome of our experience at the Singapore General Hospital.

W Luman1, K R Kwek, K L Loi, M A Chiam, W K Cheung, H S Ng.   

Abstract

INTRODUCTION: Percutaneous endoscopic gastrostomy (PEG) is widely used for patients with dysphagia from neurological causes and head and neck malignancy. We examined the indications, complication rates and long term outcome of PEG inserted in our department.
METHODS: We performed a study of PEG inserted in our department between January 1995 to March 2000. Consecutive patients with PEG inserted during this period were identified from our database that contained demographic data, primary and secondary underlying medical conditions, and immediate complications after the procedure. Casenotes were reviewed and caregivers (relatives or staff at nursing homes) were contacted for information on long term outcome at the time of this study between April 2000. Data was collected in standard form designed for this study.
RESULTS: 181 cases of PEG insertion were performed during the study period. 174 patients were successfully followed up and reviewed. The median age was 70.5 (range 24 to 93) years old and there were 111 males. Indications for PEG insertion were: cerebrovascular diseases (60.4%), Parkinson's disease and other neuromuscular disorders (10.9%), nasopharyngeal carcinoma and other upper gastrointestinal malignancies (24.7%), and head injury (4%). Superficial wound infection (22.4%) and granuloma formation (31%) were common minor complications. Major complications were infrequent: peritonitis (2.3%) and gastrointestinal bleeding (0.6%). The mortality rates were 11.5% and 28.2% at one and six months respectively. Only one death from peritonitis was directly attributed to the procedure, most deaths were due to underlying co-morbidities with pneumonia being the most common cause. The proportion of the first PEG tubes removed or replaced were 12.2% and 35.5% at one and six months respectively. Thirty tubes were replaced due to blockage at median interval of 9.6 months. 9.7% of PEG tubes functioned longer than 24 months.
CONCLUSIONS: Our results confirm the safety of PEG tubes in elderly patients with multiple co-morbidities. Major complications of the procedure were infrequent but produced grave consequences in these elderly patients with multiple co-morbidities. As such, patients considered for PEG feeding should have reasonable prognosis and the procedure is inappropriate for patients with rapidly progressive and incurable diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11874149

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  14 in total

Review 1.  Percutaneous endoscopic gastrostomy: a safe and effective bridge for enteral nutrition in neurological or non-neurological conditions.

Authors:  Rasim Gencosmanoglu
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Percutaneous endoscopic gastrostomy tube replacement: A simple procedure?

Authors:  Varut Lohsiriwat
Journal:  World J Gastrointest Endosc       Date:  2013-01-16

3.  Indications, complications and long-term follow-up of patients undergoing percutaneous endoscopic gastrostomy: A retrospective study.

Authors:  Fatih Ermis; Melih Ozel; Kemal Oncu; Yusuf Yazgan; Levent Demirturk; Ahmet Kemal Gurbuz; Taner Akyol; Hasan Nazik
Journal:  Wien Klin Wochenschr       Date:  2012-03-05       Impact factor: 1.704

4.  Risk of bleeding after percutaneous endoscopic gastrostomy (PEG).

Authors:  Dushyant Singh; Alexandra S Laya; Omkar U Vaidya; Syed A Ahmed; Aaron J Bonham; Wendell K Clarkston
Journal:  Dig Dis Sci       Date:  2011-12-03       Impact factor: 3.199

5.  Fatal intra-abdominal haemorrhage following percutaneous endoscopic gastrostomy.

Authors:  Emma Smale; Andrew M Davison; Marc Smith; Ceris Pritchard
Journal:  BMJ Case Rep       Date:  2009-08-19

6.  Comparison of clinical outcomes associated with pull-type and introducer-type percutaneous endoscopic gastrostomies.

Authors:  Sin Won Lee; Jeong Hoon Lee; Hyungjin Cho; Yeonjung Ha; Hyun Lim; Ji Yong Ahn; Kwi Sook Choi; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung; Jin-Ho Kim
Journal:  Clin Endosc       Date:  2014-11-30

7.  Bleeding risk with clopidogrel and percutaneous endoscopic gastrostomy.

Authors:  Umair Sohail; Chela Harleen; Amin O Mahdi; Murtaza Arif; Douglas L Nguyen; Matthew L Bechtold
Journal:  World J Gastrointest Endosc       Date:  2016-08-25

Review 8.  Complications of and controversies associated with percutaneous endoscopic gastrostomy: report of a case and literature review.

Authors:  Jonathan Z Potack; Sita Chokhavatia
Journal:  Medscape J Med       Date:  2008-06-17

9.  Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial.

Authors:  John Blomberg; Pernilla Lagergren; Lena Martin; Fredrik Mattsson; Jesper Lagergren
Journal:  BMJ       Date:  2010-07-02

10.  Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: a multicenter, retrospective study.

Authors:  Changhyun Lee; Jong Pil Im; Ji Won Kim; Seong-Eun Kim; Dong Yup Ryu; Jae Myung Cha; Eun Young Kim; Eun Ran Kim; Dong Kyung Chang
Journal:  Surg Endosc       Date:  2013-05-04       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.